Confirmed speakers

Allison August, Maternal Immunization Development, Novavax, U.S.A.

Richard Beigi, Vice President, Medical Affairs; Associate Professor, Magee-Womens Hospital, U.S.A.

Karin Bok, Senior Vaccine Science Advisor, Vaccine Safety Lead, National Vaccine Program Office, Department of Health and Human Services, U.S.A

Jan Bonhoeffer, President, Brighton Collaboration Foundation; Professor, University Children’s Hospital Basel, Switzerland

George Chang, National Cancer Institute, U.S.A.

Ed Clarke, Medical Research Council UK, The Gambia Unit, The Gambia

Clare Cutland, Senior Medical Officer, University of the Witwatersrand / Wits Health Consortium, Johannesburg, South Africa

Linda Eckert, Professor of Obstetrics & Gynecology, University of Washington, U.S.A.

Margarita M Gomez Lorenzo, Medical Officer, Vaccine Clinical Research Branch, Vaccine Research Program, Division of AIDS, NIAID/NIH/HHS, U.S.A.

Marion Gruber, Director, Office of Vaccines Research & Review, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, U.S.A

Linda Hanssens, Director, Medical Affairs Pediatric Vaccines, GlaxoSmithKline Biologicals, Belgium

Sonia Hernandez-Diaz, Professor of Epidemiology, Harvard T.H. Chan School of Public Health, U.S.A.

Steven Hirschfeld, Associate Director for Clinical Research, Eunice Kennedy Shriver National Institute of Child Health and

Hector Izurieta, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, U.S.A

Chrissie Jones, Clinical Lecturer, St. George's University of London, United Kingdom

Bill Kapogiannis, Program Director, Adolescent Medicine Trials Network for HIV/AIDS Interventions, Eunice Kennedy Shriver National Institute of Child Health and Human Development, U.S.A

Sonali Kochhar, CEO and Medical Director, Global Healthcare Consulting, New Delhi, India

Eve Lackritz, Deputy Director, Seattle Children's, Global Alliance to Prevent Prematurity and Stillbirth (GAPPS), U.S.A.

Tamala Mallett Moore, Global Pharmacovigilance and Epidemiology, Sanofi Pasteur, U.S.A

Anthony Marfin, Medical Epidemiologist, Japanese Encephalitis Vaccine Introduction & Sustainability Project, PATH, U.S.A.

Peter Marks, Director, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, U.S.A.

Ajoke Sobanjo-ter Meulen, Senior Program Manager, Bill & Melinda Gates Foundation, U.S.A.

Pedro Moro, Medical Epidemiologist, Centers for Disease Control and Prevention, U.S.A

Flor Muñoz, Associate Professor of Pediatrics, Baylor College of Medicine, U.S.A.

Pieter Neels, Member of the Board, IABS-EU; former CHMP member; former EMA Vaccine Working Party Vice-chair; Associate Professor University of Namur; Director, Vaccine-Advice BVBA, Belgium

Mirjana Nesin, Senior Medical Officer, NIH / NIAID / DMID, U.S.A.

Saad Omer, Professor, Global Health, Epidemiology, and Pediatrics, Emory Vaccine Center, Emory University, U.S.A.

Theresa Quinn, National Cancer Institute, U.S.A.

Alba Maria Ropero Alvarez, Unit Chief, Comprehensive Family Immunization , PAHO, U.S.A.

Christentze Schmiegelow, University of Copenhagen, Denmark

James Southern, Advisor to the South Africa Medicines Control Council, Cape Town, South Africa

James Stark, Pfizer, New York, U.S.A

Miriam Sturkenboom, Erasmus University, Rotterdam, The Netherlands

Peter Waiswa, Lead, International Network of Health Demographic Surveillance Sites, (INDEPTH Network), Uganda

Daniel Weibel, Assistant Professor, Erasmus Medical Center, The Netherlands